Dr Sharat Maxivision Eye Hospitals Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
as on 20-11-2024
- Paid Up Capital ₹ 34.82 Cr
as on 20-11-2024
- Company Age 11 Months 10 Days
- Open Charges ₹ 13.58 Cr
as on 20-11-2024
About Dr Sharat Maxivision Eye Hospitals
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 34.82 Cr.
The company currently has active open charges totaling ₹13.58 Cr.
Gomathy Kulandaivelu, Chilukuri Konduri, and Chilukuri Babu serve as directors at the Company.
- CIN/LLPIN
U86100TS2024PTC180947
- Company No.
180947
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Company Details
- Location
Warangal, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Dr Sharat Maxivision Eye Hospitals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gomathy Kulandaivelu  | Director | Current | |
| Chilukuri Konduri | Director | Current | |
| Chilukuri Babu | Director | Current |
Financial Performance and Corporate Structure Insights of Dr Sharat Maxivision Eye Hospitals.
Enhance accessibility to Dr Sharat Maxivision Eye Hospitals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dr Sharat Maxivision Eye Hospitals?
Unlock access to Dr Sharat Maxivision Eye Hospitals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Neuberg Abha Laboratory Private LimitedActive 4 years 7 monthsGomathy Kulandaivelu is a mutual person
Aloka Trivitron Medical Technologies Private LimitedActive 17 years 2 monthsGomathy Kulandaivelu is a mutual person
- Trivitron Healthcare Private LimitedActive 26 years 7 months
Gomathy Kulandaivelu is a mutual person
Dr. Ramalinga Reddy Maxivision Eye Hospitals Private LimitedActive 3 years 3 monthsGomathy Kulandaivelu is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 Apr 2021 | ₹13.58 Cr | Open |
How Many Employees Work at Dr Sharat Maxivision Eye Hospitals?
Dr Sharat Maxivision Eye Hospitals has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Sharat Maxivision Eye Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Sharat Maxivision Eye Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
